STAAR SURGICAL CO (STAA) Stock Overview
NASDAQ:STAA - US8523123052 - Common Stock
STAA Key Statistics, Chart & Performance
The current stock price of STAA is 27.47 USD. In the past month the price increased by 47.85%. In the past year, price decreased by -16.98%.
STAA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 27.15 | 40.70B | ||
| COO | COOPER COS INC/THE | 18.98 | 14.70B | ||
| SOLV | SOLVENTUM CORP | 11.99 | 12.64B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.07 | 10.28B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 24.33 | 5.27B | ||
| BLCO | BAUSCH + LOMB CORP | 34.38 | 5.11B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.71 | 3.78B | ||
| ICUI | ICU MEDICAL INC | 16.75 | 3.11B | ||
| XRAY | DENTSPLY SIRONA INC | 8.39 | 2.86B | ||
| HAE | HAEMONETICS CORP/MASS | 11.88 | 2.66B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.31 | 1.68B | ||
| NEOG | NEOGEN CORP | 17.06 | 1.22B |
Related stock screener links
About STAA
Company Profile
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 1,157 full-time employees. The firm markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). The company also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. The company makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Company Info
STAAR SURGICAL CO
1911 Walker Ave
Monrovia California CALIFORNIA 92630 US
CEO: Caren Mason
Employees: 1157
Phone: 16263037902
STAAR SURGICAL CO / STAA FAQ
What is the stock price of STAAR SURGICAL CO today?
The current stock price of STAA is 27.47 USD. The price decreased by -0.07% in the last trading session.
What is the ticker symbol for STAAR SURGICAL CO stock?
The exchange symbol of STAAR SURGICAL CO is STAA and it is listed on the Nasdaq exchange.
On which exchange is STAA stock listed?
STAA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for STAAR SURGICAL CO stock?
19 analysts have analysed STAA and the average price target is 25.12 USD. This implies a price decrease of -8.56% is expected in the next year compared to the current price of 27.47. Check the STAAR SURGICAL CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is STAAR SURGICAL CO worth?
STAAR SURGICAL CO (STAA) has a market capitalization of 1.35B USD. This makes STAA a Small Cap stock.
How many employees does STAAR SURGICAL CO have?
STAAR SURGICAL CO (STAA) currently has 1157 employees.
What are the support and resistance levels for STAAR SURGICAL CO (STAA) stock?
STAAR SURGICAL CO (STAA) has a support level at 27.46 and a resistance level at 27.96. Check the full technical report for a detailed analysis of STAA support and resistance levels.
Is STAAR SURGICAL CO (STAA) expected to grow?
The Revenue of STAAR SURGICAL CO (STAA) is expected to decline by -24.74% in the next year. Check the estimates tab for more information on the STAA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy STAAR SURGICAL CO (STAA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of STAA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of STAA, evaluating the profitability, health, valuation and growth aspects
- STAAR SURGICAL CO (STAA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- STAAR SURGICAL CO (STAA) Sales and EPS estimates to see what analysts future expectations are.
- STAAR SURGICAL CO (STAA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- STAAR SURGICAL CO (STAA) Insider and Institutional Ownership to learn about the owners and their transactions.
- STAAR SURGICAL CO (STAA) Stock Chart to make your own analysis
- STAAR SURGICAL CO (STAA) Latest news and press-releases to stay up to date.
Does STAAR SURGICAL CO (STAA) stock pay dividends?
STAA does not pay a dividend.
When does STAAR SURGICAL CO (STAA) report earnings?
STAAR SURGICAL CO (STAA) will report earnings on 2025-10-28, after the market close.
What is the Price/Earnings (PE) ratio of STAAR SURGICAL CO (STAA)?
STAAR SURGICAL CO (STAA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.99).
What is the Short Interest ratio of STAAR SURGICAL CO (STAA) stock?
The outstanding short interest for STAAR SURGICAL CO (STAA) is 13.09% of its float. Check the ownership tab for more information on the STAA short interest.
STAA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to STAA. When comparing the yearly performance of all stocks, STAA is one of the better performing stocks in the market, outperforming 79.15% of all stocks.
STAA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to STAA. No worries on liquidiy or solvency for STAA as it has an excellent financial health rating, but there are worries on the profitability.
STAA Financial Highlights
Over the last trailing twelve months STAA reported a non-GAAP Earnings per Share(EPS) of -0.99. The EPS decreased by -212.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.76% | ||
| ROE | -28.31% | ||
| Debt/Equity | 0 |
STAA Forecast & Estimates
19 analysts have analysed STAA and the average price target is 25.12 USD. This implies a price decrease of -8.56% is expected in the next year compared to the current price of 27.47.
For the next year, analysts expect an EPS growth of -574.76% and a revenue growth -24.74% for STAA